Literature DB >> 30045995

RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.

Carey A Stuart1, Erik K Zhivkoplias1, Tatiana G Senkevich1, Linda S Wyatt1, Bernard Moss2.   

Abstract

High-throughput DNA sequencing enables the study of experimental evolution in near real time. Until now, mutants with deletions of nonessential host range genes were used in experimental evolution of vaccinia virus (VACV). Here, we guided the selection of adaptive mutations that enhanced the fitness of a hybrid virus in which an essential gene had been replaced with an ortholog from another poxvirus genus. Poxviruses encode a complete system for transcription, including RNA polymerase and stage-specific transcription factors. The abilities of orthologous intermediate transcription factors from other poxviruses to substitute for those of VACV, as determined by transfection assays, corresponded with the degree of amino acid identity. VACV in which the A8 or A23 intermediate transcription factor subunit gene was replaced by the myxoma (MYX) virus ortholog exhibited decreased replication. During three parallel serial passages of the hybrid virus with the MYXA8 gene, plaque sizes and virus yields increased. DNA sequencing of virus populations at passage 10 revealed high frequencies of five different single nucleotide mutations in the two largest RNA polymerase subunits, RPO147 and RPO132, and two different Kozak consensus sequence mutations predicted to increase translation of the MYXA8 mRNA. Surprisingly, there were no mutations within either intermediate transcription factor subunit. Based on homology with Saccharomyces cerevisiae RNA polymerase, the VACV mutations were predicted to be buried within the internal structure of the enzyme. By directly introducing single nucleotide substitutions into the genome of the original hybrid virus, we demonstrated that both RNA polymerase and translation-enhancing mutations increased virus replication independently.IMPORTANCE Previous studies demonstrated the experimental evolution of vaccinia virus (VACV) following deletion of a host range gene important for evasion of host immune defenses. We have extended experimental evolution to essential genes that cannot be deleted but could be replaced by a divergent orthologous gene from another poxvirus. Replacement of a VACV transcription factor gene with one from a distantly related poxvirus led to decreased fitness as evidenced by diminished replication. Serially passaging the hybrid virus at a low multiplicity of infection provided conditions for selection of adaptive mutations that improved replication. Notably, these included five independent mutations of the largest and second largest RNA polymerase subunits. This approach should be generally applicable for investigating adaptation to swapping of orthologous genes encoding additional essential proteins of poxviruses as well as other viruses.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  evolution; homologous recombination; myxoma virus; poxvirus; transcription factors; vaccinia virus

Mesh:

Substances:

Year:  2018        PMID: 30045995      PMCID: PMC6158416          DOI: 10.1128/JVI.01089-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome.

Authors:  Chris Upton; Stephanie Slack; Arwen L Hunter; Angelika Ehlers; Rachel L Roper
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Emergence of a Viral RNA Polymerase Variant during Gene Copy Number Amplification Promotes Rapid Evolution of Vaccinia Virus.

Authors:  Kelsey R Cone; Zev N Kronenberg; Mark Yandell; Nels C Elde
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Expression profiling of the intermediate and late stages of poxvirus replication.

Authors:  Zhilong Yang; Sara E Reynolds; Craig A Martens; Daniel P Bruno; Stephen F Porcella; Bernard Moss
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

4.  Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes.

Authors:  T G Senkevich; J J Bugert; J R Sisler; E V Koonin; G Darai; B Moss
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

5.  Mapping and phenotypic analysis of spontaneous isatin-beta-thiosemicarbazone resistant mutants of vaccinia virus.

Authors:  Steven G Cresawn; Cindy Prins; Donald R Latner; Richard C Condit
Journal:  Virology       Date:  2007-03-01       Impact factor: 3.616

6.  Experimental Evolution Identifies Vaccinia Virus Mutations in A24R and A35R That Antagonize the Protein Kinase R Pathway and Accompany Collapse of an Extragenic Gene Amplification.

Authors:  Greg Brennan; Jacob O Kitzman; Jay Shendure; Adam P Geballe
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

7.  Purification of a factor required for transcription of vaccinia virus early genes.

Authors:  S S Broyles; L Yuen; S Shuman; B Moss
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

8.  An isatin-beta-thiosemicarbazone-resistant vaccinia virus containing a mutation in the second largest subunit of the viral RNA polymerase is defective in transcription elongation.

Authors:  Cindy Prins; Steven G Cresawn; Richard C Condit
Journal:  J Biol Chem       Date:  2004-08-03       Impact factor: 5.157

9.  Expansion of poxvirus RNA polymerase subunits sharing homology with corresponding subunits of RNA polymerase II.

Authors:  Bruce A Knutson; Steven S Broyles
Journal:  Virus Genes       Date:  2008-02-09       Impact factor: 2.198

10.  Adaptive gene amplification as an intermediate step in the expansion of virus host range.

Authors:  Greg Brennan; Jacob O Kitzman; Stefan Rothenburg; Jay Shendure; Adam P Geballe
Journal:  PLoS Pathog       Date:  2014-03-13       Impact factor: 6.823

View more
  6 in total

1.  Inactivation of Genes by Frameshift Mutations Provides Rapid Adaptation of an Attenuated Vaccinia Virus.

Authors:  Tatiana G Senkevich; Erik K Zhivkoplias; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

2.  Loss of the vaccinia virus 35-amino acid hydrophobic O3 protein is partially compensated by mutations in the transmembrane domains of other entry proteins.

Authors:  Andrew I Tak; Jeffrey L Americo; Ulrike S Diesterbeck; Bernard Moss
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

3.  The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.

Authors:  Amber B Rico; Alexandria C Linville; Annabel T Olson; Zhigang Wang; Matthew S Wiebe
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

4.  MAVERICC: Marker-free Vaccinia Virus Engineering of Recombinants through in vitro CRISPR/Cas9 Cleavage.

Authors:  Ethan Laudermilch; Kartik Chandran
Journal:  J Mol Biol       Date:  2021-02-24       Impact factor: 5.469

5.  A poxvirus pseudokinase represses viral DNA replication via a pathway antagonized by its paralog kinase.

Authors:  Annabel T Olson; Zhigang Wang; Amber B Rico; Matthew S Wiebe
Journal:  PLoS Pathog       Date:  2019-02-15       Impact factor: 6.823

6.  Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.

Authors:  Noam Erez; Linda S Wyatt; Jeffrey L Americo; Wei Xiao; Bernard Moss
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.